Capital Flow Monitor · Sponsors · CIK 1958777
FibroBiologics, Inc.
9350 KIRBY DRIVE, HOUSTON, TX, 77054 · 281-671-5150
Pharmaceuticals · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$4.0M
Sold
$4.0M
% sold
100.0%
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | D | 506(b) | $500K | $500K | 100.0% | 1 | EDGAR ↗ |
| 2026-06-29 | D | 506(b) | $3.0M | $3.0M | 100.0% | 1 | EDGAR ↗ |
| 2025-12-16 | D | 506(b) | $1.7M | $1.7M | 100.0% | 4 | EDGAR ↗ |
| 2025-12-03 | D | 506(b) | $1.5M | $1.5M | 100.0% | 4 | EDGAR ↗ |
| 2025-12-03 | D ·current | 506(b) | $4.0M | $4.0M | 100.0% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Pete O'Heeron — Executive Officer / Director, Houston, TX
1 other raise
- LIBERTY STAR URANIUM & METALS CORP. $4.3M of —
- Stacy Coen — Director, Houston, TX
-
Robert Hoffman — Director, Houston, TX
1 other raise
- TuHURA Biosciences, Inc./NV $1.5M of $3.0M · 50.0%
- Matthew Link — Director, Houston, TX
- Victoria Niklas — Director, Houston, TX
- Richard C. Cilento — Director, Houston, TX
- Jason D. Davis — Executive Officer, Houston, TX
Placement agents
- H.c. Wainwright & Co., Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.